🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David T. Yang

University of Wisconsin–Madison

ORCID: 0000-0002-9488-1704
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Impact of initial chemotherapy regimen on outcomes for patients with double‐expressor lymphoma: A multi‐center analysis”.

Impact of initial chemotherapy regimen on outcomes for patients with double‐expressor lymphoma: A multi‐center analysis

Hematological Oncology(2021)10.1002/hon.2902
N/A
0DataRank · unranked
13 citations

Walter Hanel, Yi Chen, Menggang Yu, David T. Yang, Ling Guo +17 more

EGR1 Addiction in Diffuse Large B-cell Lymphoma

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0267
N/A
0DataRank · unranked
16 citations

Li Lü, Nguyet M. Hoang, Fen Zhu, Paul D. Bates, Anusara Daenthanasanmak +13 more

ECOG-ACRIN E1411 randomized phase 2 trial of bendamustine-rituximab (BR)-based induction followed by rituximab (R) ± lenalidomide (L) consolidation for Mantle cell lymphoma: Effect of adding bortezomib to front-line BR induction on PFS.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7503
N/A
0DataRank · unranked
19 citations

Opeyemi A. Jegede, Peter Martin, Brian G. Till, Samir Parekh, David T. Yang +15 more

From Bench to Bedside: A Team’s Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma

Journal of Clinical Medicine(2024)10.3390/jcm13206036
N/A
0DataRank · unranked
7 citations

Regan L. Harmon, Kourtney L. Kostecki, Nellie K. McDaniel, Mari Iida, Luke W. Corday +23 more

Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer

Frontiers in Oncology(2025)10.3389/fonc.2025.1579214
N/A
0DataRank · unranked
0 citations

Regan L. Harmon, Mari Iida, Jillian M. Adams, Candie Y Lin, Christine E. Glitchev +9 more